Le Lézard
Classified in: Health
Subjects: MAV, POL, FVT, CFG

Media Advisory - Minister Hehr to announce major investment in leading-edge genomics and precision health research in Alberta


CALGARY, Jan. 22, 2018 /CNW/ - The Honourable Kent Hehr, Minister of Sport and Persons with Disabilities, on behalf of the Honourable Kirsty Duncan, Minister of Science, will announce investments being made through two of Genome Canada's premier funding programs. The investments will help some of Alberta's leading scientists advance genomics and precision health research that lead to new medical therapies to improve the health and wellbeing of Canadians.

 

Date:

January 23, 2018



Time:

9:00 a.m.



Location:

University of Calgary
EEEL Building ? 3rd Floor Landing and EEEL 214
750 Campus Drive NW 
Calgary, Alberta

 

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 11:40
The "Musculoskeletal Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Musculoskeletal Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the...

at 11:30
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of option and evaluation deals from 2016 to 2024....



News published on and distributed by: